Biogen (GB:0R1B)
LSE:0R1B
Holding GB:0R1B?
Track your performance easily

Biogen (0R1B) Financial Statements

4 Followers

Biogen Financial Overview

Biogen's market cap is currently ―. The company's EPS TTM is $7.939; its P/E ratio is 24.49; Biogen is scheduled to report earnings on October 22, 2024, and the estimated EPS forecast is $3.77. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 2.46B$ 2.29B$ 2.39B$ 2.53B$ 1.85B
Gross Profit$ 1.92B$ 1.75B$ 1.77B$ 1.87B$ 1.97B
EBIT$ 760.00M$ 677.90M$ 363.10M$ -77.40M$ 757.20M
EBITDA$ 1.01B$ 869.50M$ 503.20M$ 277.30M$ 874.60M
Net Income Common Stockholders$ 583.60M$ 393.40M$ 249.70M$ 154.70M$ 591.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 0.00$ 6.08B
Total Assets$ 26.80B$ 26.57B$ 26.84B$ 28.19B$ 25.16B
Total Debt$ 6.66B$ 6.95B$ 7.34B$ 7.72B$ 6.59B
Net Debt$ 6.66B$ 6.95B$ 7.34B$ 7.72B$ 510.70M
Total Liabilities$ 10.91B$ 11.35B$ 12.05B$ 13.71B$ 10.70B
Stockholders Equity$ 15.89B$ 15.21B$ 14.80B$ 14.48B$ 14.47B
Cash Flow-
Free Cash Flow$ 686.20M$ 432.30M$ -52.70M$ 714.50M$ 400.00M
Operating Cash Flow$ 625.80M$ 553.20M$ 12.50M$ 1.05B$ 487.00M
Investing Cash Flow$ 466.50M$ -66.00M$ -652.30M$ -2.70B$ -753.50M
Financing Cash Flow$ -245.20M$ -439.60M$ -646.10M$ 805.20M$ -9.80M
Currency in USD

Biogen Earnings and Revenue History

Biogen Debt to Assets

Biogen Cash Flow

Biogen Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis